dipyridamole has been researched along with Gastric Ulcer in 7 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 674 upper gastrointestinal bleeders, we found that the odds ratio for the presence of erosive oesophagitis in aspirin users was 2 (95% CI, 1-3; P = 0." | 3.73 | Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. ( Angerson, WJ; Blatchford, O; Knill-Jones, RP; Taha, AS, 2006) |
| "Gastric ulcer is a multifaceted, pluricausal illness." | 2.38 | Experimental gastric mucosal injury: laboratory models reveal mechanisms of pathogenesis and new therapeutic strategies. ( Glavin, GB; Szabo, S, 1992) |
| "Treatment with dipyridamole replenish the reduced level of gastric mucosal nonprotein sulfhydryls, thus suggesting the mediation of its protective effect through sulfhydryls." | 1.28 | Gastric antiulcer and cytoprotective effects of dipyridamole in rats. ( Ageel, AM; Tariq, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taha, AS | 1 |
| Angerson, WJ | 1 |
| Knill-Jones, RP | 1 |
| Blatchford, O | 1 |
| Kumashiro, R | 3 |
| Pavlides, CA | 1 |
| Kholoussy, AM | 2 |
| Matsumoto, T | 3 |
| Uberfuhr, P | 1 |
| Reichart, B | 1 |
| Welz, A | 1 |
| Kreuzer, E | 1 |
| Kemkes, BM | 1 |
| Klinner, W | 1 |
| Hammer, C | 1 |
| Ertel, W | 1 |
| Reichenspurner, H | 1 |
| Gokel, M | 1 |
| Land, W | 1 |
| Franke, N | 1 |
| Mathes, P | 1 |
| Paret, RS | 1 |
| Kodama, Y | 1 |
| Glavin, GB | 1 |
| Szabo, S | 1 |
| Tariq, M | 1 |
| Ageel, AM | 1 |
| Piotrowski, JJ | 1 |
| Hashimoto, N | 1 |
1 review available for dipyridamole and Gastric Ulcer
| Article | Year |
|---|---|
Experimental gastric mucosal injury: laboratory models reveal mechanisms of pathogenesis and new therapeutic strategies.
Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Capillaries; | 1992 |
6 other studies available for dipyridamole and Gastric Ulcer
| Article | Year |
|---|---|
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dipyrida | 2006 |
Thrombotic etiology of stress ulcers. 1. The effect of anticoagulant and antiplatelet aggregators in the development of stress ulcers in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Gastric Acidity Determination; Gastric Mucosa; Hepar | 1983 |
[Report on a successful orthotopic cardiac transplantation in Germany].
Topics: Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporins; Dipyri | 1982 |
The effect of dipyridamole on experimentally induced stress ulcers.
Topics: Animals; Dipyridamole; Gastric Acid; Gastrointestinal Hemorrhage; Hematocrit; Heparin; Male; Platele | 1982 |
Gastric antiulcer and cytoprotective effects of dipyridamole in rats.
Topics: Animals; Dipyridamole; Ethanol; Female; Gastric Mucosa; Indomethacin; Male; Rats; Rats, Inbred Strai | 1990 |
Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.
Topics: Animals; Anticoagulants; Aspirin; Capillaries; Dipyridamole; Gastric Mucosa; Male; Platelet Aggregat | 1985 |